Asia Pacific Diagnostic Imaging Devices Market By Product Type (X-ray Equipment, Ultrasound Imaging Systems, Nuclear Imaging Systems, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scanners, Others); By End User (Hospital, Home Care Setting, Ambulatory Surgical Centers, Research Institutes, Clinics); By Modality (Portable, Standalone) – Growth, Share, Opportunities & Competitive Analysis, 2021–2032
Asia Pacific Diagnostic Imaging Devices Market Overview:
The Asia Pacific Diagnostic Imaging Devices Market size was valued at USD 5,593.99 MN in 2021 and reached USD 7,143.26 MN in 2025. It is anticipated to reach USD 10,583.56 MN by 2032, growing at a CAGR of 4.71% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2021-2024
Base Year
2025
Forecast Period
2025-2032
Asia Pacific Diagnostic Imaging Devices Market Size 2025
USD 7,143.26 million
Asia Pacific Diagnostic Imaging Devices Market, CAGR
4.71%
Asia Pacific Diagnostic Imaging Devices Market Size 2032
USD 10,583.56 million
Asia Pacific Diagnostic Imaging Devices Market Insights
Market growth is supported by rising cancer diagnosis needs, hospital imaging upgrades, CT and MRI capacity expansion, ultrasound adoption, portable modality demand and AI-enabled imaging workflows.
Computed Tomography (CT) Scanners hold a strong position because CT supports emergency care, oncology staging, trauma assessment, cardiovascular imaging and infectious disease evaluation.
Ultrasound Imaging Systems are gaining momentum due to broad use in obstetrics, cardiology, abdominal imaging, point-of-care settings and outpatient clinics.
Hospitals remain the leading end-user segment because advanced diagnostic imaging devices require radiology departments, trained operators, image storage systems, service contracts and reimbursement coordination.
Asia Pacific Diagnostic Imaging Devices Market Segment Insights
By product type
By product type, Computed Tomography (CT) Scanners held a strong position in 2025 because hospitals and diagnostic centers use CT for emergency diagnosis, oncology staging, stroke evaluation, trauma care, chest imaging and cardiovascular assessment. Magnetic Resonance Imaging (MRI) remains a high-value category due to strong use in neurology, oncology, orthopedics and cardiovascular imaging. X-ray Equipment remains a high-volume modality because it supports first-line screening, trauma assessment, chest imaging and outpatient diagnostics. Ultrasound Imaging Systems are expanding due to portability, real-time visualization, lower radiation concerns and broad use in maternal care, abdominal imaging and cardiology. Nuclear Imaging Systems remain important for oncology, cardiology and metabolic assessment. Others include mammography, fluoroscopy, hybrid imaging support and image-guided systems.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
By end user, Hospital held the strongest position in 2025 because advanced imaging systems require dedicated radiology infrastructure, trained technologists, radiologists, shielding, installation support, service contracts and integration with hospital information systems. Clinics support X-ray, ultrasound and selected portable imaging demand due to outpatient diagnostics and primary care referrals. Ambulatory Surgical Centers are gaining relevance as outpatient procedures require intraoperative imaging, ultrasound guidance and C-arm support. Research Institutes use advanced imaging systems for clinical trials, AI development and biomedical research. Home Care Setting remains smaller but is gaining relevance through portable ultrasound, remote monitoring-linked imaging and post-acute care models.
By modality
By modality, Standalone held the strongest position in 2025 because MRI, CT, nuclear imaging and high-throughput X-ray systems require fixed installation, controlled rooms, shielding, power systems and service infrastructure. Standalone systems dominate hospitals, large clinics and diagnostic centers where scan volume and image quality requirements are high. Portable modality demand is rising because hospitals, emergency departments, intensive care units, rural facilities and mobile care providers need flexible imaging access. Portable ultrasound, mobile X-ray and mobile CT systems support faster bedside diagnosis, outreach care and imaging access in underserved locations. Growth will depend on affordability, battery performance, image quality, AI support and connectivity.
Key Market Drivers
Cancer burden and advanced imaging demand
Cancer burden and advanced imaging demand represent major growth drivers for the Asia Pacific Diagnostic Imaging Devices Market. Cancer diagnosis and treatment planning depend heavily on CT, MRI, ultrasound, X-ray, nuclear imaging and image-guided workflows. WHO estimated that the Western Pacific Region recorded close to 6.8 million new cancer cases in 2022, while the WHO South-East Asia Region recorded 2.37 million new cases and 1.53 million deaths in 2022. This large disease burden supports demand for Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI), Ultrasound Imaging Systems, Nuclear Imaging Systems and hospital-based diagnostic imaging services. Growth will remain strongest in countries expanding oncology centers, cancer screening, radiotherapy planning, molecular imaging and image-guided treatment pathways.
Medical technology access and imaging capacity expansion
Medical technology access and imaging capacity expansion support market growth because Asia Pacific health systems need more diagnostic equipment to reduce waiting times, improve geographic access and support early disease detection. OECD/WHO reported that CT scanners and MRI units help doctors diagnose internal organs and body structures, while too few units can create access problems in geographic proximity or waiting times. The same report notes wide regional gaps in medical technology availability, with higher-income markets showing greater equipment availability than many lower-resource Asia Pacific countries. This driver supports Standalone systems, Hospital end users, Clinics, X-ray Equipment, CT Scanners and MRI. Expansion will depend on public hospital investment, reimbursement, service networks and trained imaging workforce availability.
Infectious disease diagnosis and chest imaging needs
Infectious disease diagnosis and chest imaging needs sustain demand for X-ray Equipment, CT Scanners and portable imaging devices across Asia Pacific. TB, pneumonia and respiratory infections require diagnostic workflows that often include chest radiography or CT when clinically indicated. WHO reported that the South-East Asia Region continues to account for more than one in every three new TB cases worldwide and identified India, Bangladesh, Myanmar and Thailand among global high TB burden countries in the region. WHO also noted that the South-East Asia Region accounted for more than 45% of the global TB burden in 2023 and highlighted upfront chest X-ray screening within strategies to strengthen pediatric TB diagnosis. This driver supports X-ray Equipment, Portable modality, Clinics and Hospitals.
AI-enabled imaging and vendor innovation
AI-enabled imaging and vendor innovation are strengthening replacement demand and premium system adoption. Manufacturers are embedding AI into CT, MRI, X-ray and ultrasound systems to improve workflow speed, image quality, scan consistency and radiologist productivity. Siemens Healthineers showcased a broad diagnostic imaging portfolio at AOCR 2025 in Chennai, including virtually helium-free 1.5T MAGNETOM Flow MRI, SOMATOM Pro.Pulse CT, MULTIX Impact E digital X-ray systems and AI-powered ACUSON ultrasound systems. Philips launched its AI-enabled CT 5300 at AOCR 2025 and showcased AI-driven solutions across MRI, CT, ultrasound and enterprise informatics portfolios. This driver supports MRI, CT Scanners, Ultrasound Imaging Systems, X-ray Equipment, Hospitals and Research Institutes.
Hospital and diagnostic center investment in high-value imaging systems
Hospital and diagnostic center investment in high-value imaging systems is accelerating market growth as providers expand scan capacity, replace aging systems and improve diagnostic throughput. GE HealthCare reported 2025 revenue of USD 20.6 billion, up 4.8%, with growth driven by Imaging, Pharmaceutical Diagnostics and Advanced Visualization Solutions. It also reported Imaging organic revenue of USD 9.195 billion in 2025, up 3.8%. Siemens Healthineers reported 6.5% comparable revenue growth in Imaging for fiscal 2025 and adjusted EBIT margin of 20.6%, indicating sustained global imaging demand. These company trends support CT Scanners, MRI, Ultrasound Imaging Systems, Hospitals and standalone modality upgrades.
Portable imaging is expanding access beyond radiology departments as hospitals, emergency rooms, ICUs, ambulatory care settings and rural facilities seek faster bedside diagnosis. Portable ultrasound and mobile X-ray systems support high-frequency examinations, while mobile CT systems support emergency, ICU and neurology use cases. Samsung launched the R20 ultrasound system in India in 2025, positioning it as a next-generation system with AI-driven technologies, advanced hardware and improved ergonomics. Portable modality growth will depend on image quality, battery life, wireless connectivity, AI tools, training and affordability. This trend supports Home Care Setting, Clinics, Hospitals and Ambulatory Surgical Centers.
AI and workflow automation become system differentiators
AI and workflow automation are becoming key differentiators in diagnostic imaging devices. Imaging departments face rising scan volumes, radiologist workload pressure and the need for consistent image quality. AI-enabled scan planning, image reconstruction, lesion detection, report support and workflow prioritization can help hospitals increase throughput and reduce repeat scans. GE HealthCare introduced advanced imaging solutions powered by NVIDIA technology in 2025, including imaging concepts across MRI, X-ray and ultrasound with edge AI and accelerated computing platforms. This trend supports Research Institutes, Hospitals, CT Scanners, MRI and Ultrasound Imaging Systems.
Local and regional manufacturing strengthens equipment availability
Local and regional manufacturing is strengthening equipment availability as Asia Pacific countries seek cost-effective diagnostic imaging supply, faster service support and reduced import dependence. India developed its first indigenous MRI machine, with installation at AIIMS Delhi for trials planned in 2025, according to India’s public broadcaster DD News. United Imaging Healthcare reported that Asia Pacific regional revenue grew by more than 40% in 2025 and that the launch of the uSONIQUE ultrasound series completed its imaging portfolio. This trend supports Standalone systems, Portable systems, Clinics, Hospitals and regional service networks.
Premium ultrasound and CT platforms gain traction
Premium ultrasound and CT platforms are gaining traction because providers need faster exams, better image resolution, AI support and lower operational burden. Canon Medical introduced Aplio beyond in 2025 as a premium ultrasound solution for demanding, high-throughput clinical environments, with AI-enabled tools and a compact, silent housing. Canon’s 2025 press releases also highlighted continued CT portfolio development and MRI innovation, including real-time cardiac scanning without breath-holding. This trend supports Ultrasound Imaging Systems, CT Scanners, MRI and Hospitals. Vendors with strong service, training and financing support will gain advantage.
Key Market Challenges
High equipment cost and reimbursement pressure
High equipment cost and reimbursement pressure remain major challenges for the Asia Pacific Diagnostic Imaging Devices Market. MRI, CT scanners, nuclear imaging systems and advanced ultrasound systems require high upfront capital, installation spending, shielding, facility modification, maintenance contracts and trained staff. Lower-resource markets may struggle to justify investment without reimbursement support or sufficient scan volume. Hospitals and clinics must balance equipment upgrades with budget limits, staffing constraints and patient affordability. Cost pressure is especially important in emerging markets where imaging access gaps remain wide. Vendors must offer financing, managed equipment services, refurbished options and value-tier systems to expand adoption.
Radiologist and technologist workforce shortages
Radiologist and technologist workforce shortages can limit effective device utilization. Diagnostic imaging growth requires trained radiologists, sonographers, radiographers, physicists, biomedical engineers and service personnel. Advanced MRI, nuclear imaging, CT protocols and AI-enabled systems require training and quality control. Shortages are more severe outside major urban hospitals, limiting the impact of equipment installation in rural or secondary facilities. Portable imaging can improve access, but it still requires operator training and remote reporting support. Health systems must invest in workforce development, teleradiology networks and standardized imaging protocols.
Regulatory, procurement and service complexity
Regulatory, procurement and service complexity can delay imaging device adoption. Hospitals must manage product approvals, tenders, import duties, installation planning, service contracts, cybersecurity, software updates and lifecycle compliance. Japan’s government procurement notices in 2025 included X-ray CT imaging devices and MRI and diagnostic imaging support network systems, showing the formal procurement complexity around advanced imaging equipment. Service complexity is also high because imaging systems require uptime, calibration, spare parts, engineer access and cybersecurity support. Vendors with local service networks and clear lifecycle support will be better positioned.
Uneven access across urban and rural markets
Uneven access across urban and rural markets remains a structural challenge. Large hospitals in China, Japan, South Korea, Australia, Singapore and India’s metropolitan centers can adopt advanced MRI, CT, nuclear imaging and AI-enabled systems more quickly. Rural hospitals, public clinics and smaller diagnostic centers often face capital limitations, workforce shortages and lower utilization. OECD/WHO noted that too few CT and MRI units can create access problems related to geographic proximity and waiting times. Portable systems, hub-and-spoke reporting models and regional public procurement will be essential to reduce the access gap.
Regional Analysis
China
China represents a major market within the Asia Pacific Diagnostic Imaging Devices Market due to its large hospital system, strong public procurement, domestic imaging manufacturers and expanding oncology, cardiovascular and emergency care demand. CT Scanners, MRI, Ultrasound Imaging Systems and X-ray Equipment remain core product categories. Domestic players such as United Imaging and Neusoft compete with global vendors across hospitals and diagnostic centers. United Imaging reported more than 40% year-over-year revenue growth in Asia Pacific in 2025 and expanded its ultrasound portfolio with uSONIQUE, strengthening its regional imaging platform. Growth will depend on procurement policy, hospital budgets, localization, service capability and AI-enabled system adoption.
Japan
Japan is a mature diagnostic imaging market supported by advanced hospitals, high CT and MRI utilization, strong regulatory quality and early adoption of premium imaging systems. OECD/WHO reported that Japan has very high medical technology availability compared with many Asia Pacific peers, including 57 MRI units per million population in the region’s medical technology comparison. Hospitals dominate demand for MRI, CT, nuclear imaging and high-end ultrasound systems. Clinics also support ultrasound and X-ray demand. Growth will depend on replacement cycles, aging population needs, AI workflow adoption, reimbursement and compact high-productivity systems.
India
India is an expanding market supported by rising hospital investment, cancer diagnosis needs, TB screening, private diagnostic center growth and local manufacturing initiatives. X-ray Equipment and Ultrasound Imaging Systems remain important for broad access, while CT and MRI demand is growing in tertiary hospitals and private diagnostic chains. India’s development of its first indigenous MRI machine for AIIMS Delhi trials signals growing national focus on lowering costs and reducing import dependence. Siemens Healthineers and Philips also used AOCR 2025 in Chennai to showcase advanced MRI, CT, X-ray and ultrasound technologies. Growth will depend on affordability, local service, reimbursement and skilled workforce availability.
South Korea
South Korea represents a high-value market supported by advanced hospitals, strong medical technology adoption, domestic ultrasound expertise and digital health infrastructure. Ultrasound Imaging Systems, CT Scanners, MRI and monitoring-linked diagnostic workflows are important categories. Samsung Medison strengthens the country’s role in ultrasound innovation, and Samsung introduced the AI-enabled R20 ultrasound system in 2025. Hospitals and Clinics remain key end users, while Research Institutes support imaging AI, radiology software and device development. Growth will depend on replacement cycles, export-oriented device innovation, hospital technology upgrades and integration with AI-enabled radiology workflows.
Australia and New Zealand
Australia and New Zealand represent mature diagnostic imaging markets supported by public reimbursement, advanced hospitals, private imaging centers and regulated device access. Australia’s Department of Health published Diagnostic Imaging Medicare quarterly statistics for the March quarter 2025–26, showing ongoing government tracking of diagnostic imaging utilization and reimbursement activity. CT Scanners, MRI, Ultrasound Imaging Systems and X-ray Equipment remain important across hospitals, clinics and ambulatory care settings. Growth will depend on Medicare eligibility, private imaging network investment, workforce availability, rural access needs and replacement of older systems.
Southeast Asia
Southeast Asia offers long-term growth potential as hospitals, private diagnostic centers and public health systems expand imaging infrastructure. Singapore leads in premium imaging adoption, while Thailand, Malaysia, Indonesia, Vietnam and the Philippines are increasing demand for CT, MRI, X-ray, ultrasound and portable imaging at different speeds. WHO states that diagnostic devices, including imaging devices, are critical enablers of universal health coverage in the South-East Asia Region. Growth will depend on affordability, tendering, public hospital investment, service infrastructure, trained radiology workforce and mobile imaging access in underserved areas.
Report Attribute Details
Report Attribute
Details
Historical Period
2021–2024
Base Year
2025
Forecast Period
2025–2032
Market Size in 2021
USD 5,593.99 MN
Market Size in 2025
USD 7,143.26 MN
Market Size in 2032
USD 10,583.56 MN
CAGR
4.71%
Segments Covered
Product Type, End User, Modality and Geography
Key Companies Covered
General Electric Company, Hitachi Ltd., Hologic, Inc., Koninklijke Philips N.V., Samsung Medison Co., Ltd., Shimadzu Medical Pvt. Ltd., CANON MEDICAL SYSTEM CORPORATION, ESAOTE SPA, Allengers, Siemens Healthcare Private Limited, Neusoft Corporation, NP JSC AMICO and Shanghai Lianying Medical Technology Co., Ltd.
Asia Pacific Diagnostic Imaging Devices Market Segmentations
By Product Type
X-ray Equipment
Ultrasound Imaging Systems
Nuclear Imaging Systems
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) Scanners
Others
By End User
Hospital
• Home Care Setting
• Ambulatory Surgical Centers
• Research Institutes
• Clinics
By Modality
Portable
Standalone
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In 2025, Siemens Healthineers showcased diagnostic imaging solutions at AOCR 2025 in Chennai, including MAGNETOM Flow MRI, SOMATOM Pro.Pulse CT, MULTIX Impact E digital X-ray systems and AI-powered ACUSON ultrasound systems.
In 2025, Philips launched its AI-enabled CT 5300 at AOCR 2025 and showcased AI-driven MRI, CT, ultrasound and enterprise informatics solutions for the Indian subcontinent.
In February 2025, Canon Medical introduced Aplio beyond, a premium ultrasound solution for demanding, high-throughput clinical environments with AI-enabled tools.
In 2025, Samsung introduced the R20 Ultrasound System with AI-driven technologies and advanced hardware to improve ultrasound imaging performance and precision.
In 2025, United Imaging Healthcare reported Asia Pacific revenue growth of more than 40% and launched the uSONIQUE ultrasound series, completing its imaging portfolio.
Report Coverage
The research report offers an in-depth analysis based on product type, end user, modality and geography. It details leading market players, providing an overview of their business positioning, diagnostic imaging portfolios, X-ray systems, ultrasound imaging systems, nuclear imaging systems, MRI systems, CT scanners, portable systems, standalone equipment, AI-enabled imaging tools and strategic relevance in the Asia Pacific Diagnostic Imaging Devices Market. The report includes insights into the competitive environment, market trends, growth drivers, restraints and opportunities. It also examines cancer burden, TB screening needs, hospital imaging upgrades, medical technology access gaps, AI-enabled imaging innovation, portable modality expansion, local manufacturing and procurement complexity as major factors shaping market development. The report assesses the impact of high equipment cost, reimbursement pressure, workforce shortages, installation requirements, regulatory complexity, service limitations and uneven rural access on market growth. It provides strategic recommendations for diagnostic imaging device manufacturers, hospitals, clinics, ambulatory surgical centers, research institutes, distributors, investors and new entrants seeking to navigate Asia Pacific’s diagnostic imaging devices ecosystem.
Future Outlook
Demand for diagnostic imaging devices will continue to rise as Asia Pacific health systems expand early diagnosis, cancer care, emergency medicine and chronic disease management.
CT Scanners will remain a major product category due to use in emergency care, oncology staging, trauma, stroke and respiratory disease evaluation.
MRI will remain a high-value segment due to neurology, oncology, orthopedics and cardiovascular imaging demand.
Ultrasound Imaging Systems will gain momentum through portability, lower radiation concerns, point-of-care use and AI-enabled workflow tools.
X-ray Equipment will remain a high-volume modality because it supports first-line screening, chest imaging and outpatient diagnostics.
Nuclear Imaging Systems will support oncology, cardiology and metabolic disease assessment in advanced hospitals.
Hospitals will remain the leading end-user segment due to advanced infrastructure, radiology departments and high scan volumes.
Clinics and Ambulatory Surgical Centers will gain relevance as imaging shifts closer to outpatient and procedural care settings.
Portable modality will grow as hospitals, rural facilities and mobile care providers seek flexible bedside diagnostic access.
Competition will increase as companies compete on AI capabilities, image quality, service uptime, financing models, regional manufacturing, compact design and training support.
Table of Contents (The complete Toc, LoF and LoT are available in the sample report)
Chapter No. 1: Introduction
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP and Key Offerings
1.2. Key Benefits for Stakeholders
1.3. Target Audience
Chapter No. 2: Executive Summary
Chapter No. 3: Asia Pacific Diagnostic Imaging Devices Market forces and industry pulse
3.1. Introduction
3.2. Catalysts of Expansion – Key Market Drivers
3.2.1. Cancer burden and advanced imaging demand
3.2.2. Medical technology access and imaging capacity expansion
3.2.3. Infectious disease diagnosis and chest imaging needs
3.2.4. AI-enabled imaging and vendor innovation
3.2.5. Hospital and diagnostic center investment in high-value imaging systems
3.3. Market Restraints
3.3.1. High equipment cost and reimbursement pressure
3.3.2. Radiologist and technologist workforce shortages
3.3.3. Regulatory, procurement and service complexity
3.3.4. Uneven access across urban and rural markets
3.4. Untapped Horizons – Growth Potential and Opportunities; Strategic Navigation – Industry Frameworks
3.4.1. Portable imaging expands access beyond radiology departments
3.4.2. AI and workflow automation become system differentiators
3.4.3. Local and regional manufacturing strengthens equipment availability
3.4.4. Premium ultrasound and CT platforms gain traction
Chapter No. 4: Competition Analysis
4.1. Company Market Share Analysis
4.1.1. Asia Pacific Diagnostic Imaging Devices Market Company Revenue Market Share, 2025
4.2. Strategic Developments
4.3. Competitive Dashboard
4.4. Company Assessment Metrics, 2025
Chapter No. 5: Asia Pacific Market Analysis, Insights and Forecast, by Product Type
Chapter No. 6: Asia Pacific Market Analysis, Insights and Forecast, by End User
Chapter No. 7: Asia Pacific Market Analysis, Insights and Forecast, by Modality
Chapter No. 8: Asia Pacific Market Analysis, Insights and Forecast, by Geography
8.1. China
8.2. Japan
8.3. India
8.4. South Korea
8.5. Australia and New Zealand
8.6. Southeast Asia
8.7. Rest of Asia Pacific
Chapter No. 9: Company Profile
9.1. General Electric Company
9.2. Hitachi Ltd.
9.3. Hologic, Inc.
9.4. Koninklijke Philips N.V.
9.5. Samsung Medison Co., Ltd.
9.6. Shimadzu Medical Pvt. Ltd.
9.7. CANON MEDICAL SYSTEM CORPORATION
9.8. ESAOTE SPA
9.9. Allengers
9.10. Siemens Healthcare Private Limited
9.11. Neusoft Corporation
9.12. NP JSC AMICO
9.13. Shanghai Lianying Medical Technology Co., Ltd.
List of figures
Fig No. 1: Asia Pacific Diagnostic Imaging Devices Market Revenue Share, by Product Type, 2025 and 2032
Fig No. 2: Market Attractiveness Analysis, by Product Type
Fig No. 3: Incremental Revenue Growth Opportunity by Product Type, 2025–2032
Fig No. 4: Asia Pacific Diagnostic Imaging Devices Market Revenue Share, by End User, 2025 and 2032
Fig No. 5: Incremental Revenue Growth Opportunity by End User, 2025–2032
Fig No. 6: Asia Pacific Diagnostic Imaging Devices Market Revenue Share, by Modality, 2025 and 2032
Fig No. 7: Asia Pacific Diagnostic Imaging Devices Market Revenue Share, by Geography, 2025 and 2032
Fig No. 8: Market Attractiveness Analysis, by Geography
List of tables
Table No. 1: Asia Pacific Diagnostic Imaging Devices Market Revenue, by Product Type, 2021–2025 (USD MN)
Table No. 2: Asia Pacific Diagnostic Imaging Devices Market Revenue, by Product Type, 2026–2032 (USD MN)
Table No. 3: Asia Pacific Diagnostic Imaging Devices Market Revenue, by End User, 2021–2025 (USD MN)
Table No. 4: Asia Pacific Diagnostic Imaging Devices Market Revenue, by End User, 2026–2032 (USD MN)
Table No. 5: Asia Pacific Diagnostic Imaging Devices Market Revenue, by Modality, 2021–2025 (USD MN)
Table No. 6: Asia Pacific Diagnostic Imaging Devices Market Revenue, by Modality, 2026–2032 (USD MN)
Table No. 7: Asia Pacific Diagnostic Imaging Devices Market Revenue, by Geography, 2021–2025 (USD MN)
Table No. 8: Asia Pacific Diagnostic Imaging Devices Market Revenue, by Geography, 2026–2032 (USD MN)
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for the Asia Pacific Diagnostic Imaging Devices Market and what is its projected size in 2032?
The Asia Pacific Diagnostic Imaging Devices Market was valued at USD 7,143.26 MN in 2025 and is projected to reach USD 10,583.56 MN by 2032.
At what CAGR is the Asia Pacific Diagnostic Imaging Devices Market projected to grow?
The Asia Pacific Diagnostic Imaging Devices Market is projected to grow at a CAGR of 4.71% during the forecast period.
Which product type segment is expected to hold strong demand?
Computed Tomography (CT) Scanners are expected to hold strong demand because they support emergency care, oncology staging, trauma, cardiovascular imaging and infectious disease evaluation.
Which modality leads the market?
Standalone modality leads the market because MRI, CT, nuclear imaging and high-throughput X-ray systems require fixed installation, controlled rooms and service infrastructure.
Which end-user segment leads the market?
Hospitals lead the market because advanced diagnostic imaging devices require radiology departments, trained operators, service contracts and information system integration.
Who are the leading companies in the market?
The leading companies include General Electric Company, Hitachi Ltd., Hologic, Inc., Koninklijke Philips N.V., Samsung Medison Co., Ltd., Shimadzu Medical Pvt. Ltd., CANON MEDICAL SYSTEM CORPORATION, ESAOTE SPA, Allengers, Siemens Healthcare Private Limited, Neusoft Corporation, NP JSC AMICO and Shanghai Lianying Medical Technology Co., Ltd.
Which countries are important in the Asia Pacific market?
China, Japan, India, South Korea, Australia, New Zealand and Southeast Asian countries are important markets due to hospital investment, diagnostic access needs, local manufacturing, public procurement and growing imaging utilization.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Middle East In Vitro Diagnostics Market size was valued at USD 2,568.78 MN in 2021 and reached USD 3,194.98 MN in 2025. It is anticipated to reach USD 4,546.99 MN by 2032, growing at a CAGR of 4.22% during the forecast period.
Balloon Infusers Market size was valued USD 2364 million in 2024 and is anticipated to reach USD 3575.3 million by 2032, at a CAGR of 5.31% during the forecast period.
The global Digital Therapeutic Devices Market size was estimated at USD 6,450.70 million in 2025 and is expected to reach USD 15,410.07 million by 2032, growing at a CAGR of 15.62% from 2025 to 2032.
The North America Cardiovascular Drugs Market size was valued at USD 35,146.60 MN in 2021 and reached USD 46,140.28 MN in 2025. It is anticipated to reach USD 70,300.43 MN by 2032, growing at a CAGR of 5.01% during the forecast period.
The North America Anticancer Drugs/Oncology Drugs Market size was valued at USD 64,394.03 MN in 2021 and reached USD 87,086.19 MN in 2025. It is anticipated to reach USD 150,370.53 MN by 2032, growing at a CAGR of 6.76% during the forecast period.
The DNA Forensics Market size was estimated at USD 6,940.47 million in 2025 and is expected to reach USD 11,601.47 million by 2032, growing at a CAGR of 8.94% from 2025 to 2032.
The global healthcare POS terminals market was valued at USD 16,218 million in 2024 and is projected to reach USD 35,840.49 million by 2032, expanding at a compound annual growth rate (CAGR) of 10.42% during the forecast period, according to Credence Research.
The global healthcare analytical testing market was valued at USD 8,183 million in 2024 and is projected to reach USD 18,870.73 million by 2032, expanding at a compound annual growth rate (CAGR) of 11.01% during the forecast period,
The Global Optogenetics market size was valued at USD 118 million in 2024 and is anticipated to reach USD 180.24 million by 2032, growing at a CAGR of 5.46% during the forecast period.
The glycated albumin assay market was valued at USD 613 million in 2024 and is projected to reach USD 1,135.21 million by 2032, registering a CAGR of 8% during the forecast period.
The pregelatinized starch market reached USD 3,344.5 million in 2024 and is projected to reach USD 4,626.7 million by 2032, growing at a CAGR of 4.14% during the forecast period. (Credence Research)
The pregnancy detection kits market reached USD 1,694.5 million in 2024 and is projected to reach USD 2,541.95 million by 2032, growing at a CAGR of 5.2% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
